Revisiting the X: BOT Naltrexone Clinical Trial Using a Comprehensive Survival Analysis
This paper illustrates survival models for analysis of trials of substance use treatment programs. It uses public release data from a study of extended-release naltrexone (XR-NTX), relative to buprenorphine-naloxone (BUP-NX).
Posted Date
07/06/22